Phase II trial of methylene dimethane sulphonate (MDMS) in advanced soft tissue sarcomas of the adult. A study of the EORTC Soft Tissue and Bone Sarcoma Group.
作者信息
Steward W P, Mouridsen H T, Kerbrat P, Somers R, Verweij J, Van Oosterom A T, Blackledge G, Havsteen H, Thomas D, Sylvester R
机构信息
Christie Hospital, Manchester, U.K.
出版信息
Eur J Cancer Clin Oncol. 1989 Aug;25(8):1251-3. doi: 10.1016/0277-5379(89)90423-9.
PMID:2767113
Abstract
摘要
相似文献
1
Phase II trial of methylene dimethane sulphonate (MDMS) in advanced soft tissue sarcomas of the adult. A study of the EORTC Soft Tissue and Bone Sarcoma Group.
Eur J Cancer Clin Oncol. 1989 Aug;25(8):1251-3. doi: 10.1016/0277-5379(89)90423-9.
2
A negative phase II trial methylene dimethane sulphonate in advanced ovarian cancer (Cancer Research Campaign Phase I/II Trials Committee).一项关于亚甲基二磺酸在晚期卵巢癌中的阴性II期试验（癌症研究运动I/II期试验委员会）
Br J Cancer. 1988 May;57(5):512-3. doi: 10.1038/bjc.1988.116.
3
Phase I clinical trial of methylene dimethane sulfonate.
Cancer Treat Rep. 1987 Sep;71(9):817-20.
4
A phase II study of M-azido-pyrimethamine ethane sulphonate (MZPES) in advanced, recurrent soft tissue sarcoma. An EORTC Soft Tissue and Bone Sarcoma Group Study.M-叠氮基乙磺酸盐嘧啶胺（MZPES）用于晚期复发性软组织肉瘤的II期研究。欧洲癌症研究与治疗组织软组织和骨肉瘤研究组的一项研究。
Eur J Cancer Clin Oncol. 1989 Dec;25(12):1891-3. doi: 10.1016/0277-5379(89)90366-0.
5
Phase II study of 1,2,4-triglycidyl urasol (TGU) in advanced soft tissue sarcoma. A trial of the EORTC Soft Tissue and Bone Sarcoma Cooperative Group.1,2,4-三缩水甘油基乌拉索（TGU）用于晚期软组织肉瘤的II期研究。欧洲癌症研究与治疗组织软组织和骨肉瘤合作组的一项试验。
Eur J Cancer Clin Oncol. 1987 Sep;23(9):1413-4. doi: 10.1016/0277-5379(87)90129-5.
6
VP-16 in advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and bone sarcoma group.依托泊苷治疗晚期软组织肉瘤：欧洲癌症研究与治疗组织软组织和骨肉瘤组的一项II期研究
Eur J Cancer Clin Oncol. 1987 May;23(5):579-80. doi: 10.1016/0277-5379(87)90324-5.
7
Mitomycin C (MCC) in advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group.丝裂霉素C（MCC）治疗晚期软组织肉瘤：欧洲癌症研究与治疗组织软组织和骨肉瘤组的一项II期研究
Eur J Cancer Clin Oncol. 1985 Apr;21(4):459-61. doi: 10.1016/0277-5379(85)90037-9.
8
Phase II study of miltefosine (hexadecylphosphocholine) in advanced soft tissue sarcomas of the adult--an EORTC Soft Tissue and Bone Sarcoma Group Study.
Eur J Cancer. 1993;29A(2):208-9. doi: 10.1016/0959-8049(93)90177-h.
9
Phase II study of fotemustine in advanced soft tissue sarcomas. A trial of the EORTC Soft Tissue and Bone Sarcoma Group.福莫司汀治疗晚期软组织肉瘤的II期研究。欧洲癌症研究与治疗组织软组织和骨肉瘤组的一项试验。
Eur J Cancer. 1992;29A(1):143-4. doi: 10.1016/0959-8049(93)90594-6.
10
Phase II study of mitozolomide in advanced soft tissue sarcoma of adults: the EORTC Soft Tissue and Bone Sarcoma Group.
Eur J Cancer. 1992;28A(4-5):855-7. doi: 10.1016/0959-8049(92)90132-l.
Zotero 插件